Semaglutide has emerged as a novel treatment for type 2 diabetes. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to produce more insulin and suppressing glucagon production. Furthermore, semaglutide displays potential applications beyond diabetes management, spanning weight loss and potentially

Semaglutide has gained significant recognition in recent years as a medication for treating type 2 diabetes and obesity. This potent glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting weight loss. Understanding how semaglutide functions is essential for individual